Cancer Stem Cells and Microenvironment in Prostate Cancer Progression

Hormones and Cancer

Volumn 1, Issue 6, 2010, Pages 297-305

  Liao, Chun Peng ^a   Adisetiyo, Helty ^a   Liang, Mengmeng ^a   Roy Burman, Pradip ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cancer associated fibroblasts; Heterotypic cell cell interactions in prostate cancer; Mouse models of prostate cancer; Prostate cancer; Prostate cancer stem cells

Indexed keywords

ATAXIN 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER GROWTH; CANCER STEM CELL; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; CELL SUBPOPULATION; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SPHEROID CELL;

ADENOCARCINOMA; ANIMALS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINEAGE; COCULTURE TECHNIQUES; DISEASE PROGRESSION; FIBROBLASTS; MALE; MICE; MICE, TRANSGENIC; NEOPLASTIC STEM CELLS; PROSTATIC NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 78650226302     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-010-0051-5     Document Type: Article

References (78)

1. Al-Hajj M, Clarke MF (2004) Self-renewal and solid tumor stem cells. Oncogene 23: 7274-7282.
2. Reya T, Morrison SJ, Clarke MF et al (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
3. Isaacs JT, Coffey DS (1989) Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl 2: 33-50.
4. Signoretti S, Pires MM, Lindauer M et al (2005) p63 regulates commitment to the prostate cell lineage. Proc Natl Acad Sci USA 102: 11355-11360.
5. Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
6. Al-Hajj M, Wicha MS, Benito-Hernandez A et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988.
7. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
8. Kim CF, Jackson EL, Woolfenden AE et al (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835.
9. Ma S, Chan KW, Hu L et al (2007) Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132: 2542-2556.
10. Li C, Heidt DG, Dalerba P et al (2007) Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037.
11. Ferrandina G, Bonanno G, Pierelli L et al (2008) Expression of CD133-1 and CD133-2 in ovarian cancer. Int J Gynecol Cancer 18: 506-514.
12. Prince ME, Sivanandan R, Kaczorowski A et al (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104: 973-978.
13. Fang D, Nguyen TK, Leishear K et al (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65: 9328-9337.
14. Collins AT, Berry PA, Hyde C et al (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951.
15. Mbeunkui F, Johann DJ Jr (2009) Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother Pharmacol 63: 571-582.
16. Hu M, Polyak K (2008) Microenvironmental regulation of cancer development. Curr Opin Genet Dev 18: 27-34.
17. Mueller MM, Fusenig NE (2004) Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849.
18. Orimo A, Weinberg RA (2006) Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5: 1597-1601.
19. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420: 860-867.
20. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659.
21. Olumi AF, Grossfeld GD, Hayward SW et al (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-5011.
22. Cunha GR, Hayward SW, Wang YZ et al (2003) Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107: 1-10.
23. Hill R, Song Y, Cardiff RD et al (2005) Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123: 1001-1011.
24. Fukino K, Shen L, Matsumoto S et al (2004) Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res 64: 7231-7236.
25. Kurose K, Gilley K, Matsumoto S et al (2002) Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 32: 355-357.
26. Matsumoto N, Yoshida T, Yamashita K et al (2003) Possible alternative carcinogenesis pathway featuring microsatellite instability in colorectal cancer stroma. Br J Cancer 89: 707-712.
27. Moinfar F, Man YG, Arnould L et al (2000) Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 60: 2562-2566.
28. Tuhkanen H, Anttila M, Kosma VM et al (2004) Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. Int J Cancer 109: 247-252.
29. Allinen M, Beroukhim R, Cai L et al (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32.
30. de Visser KE, Korets LV, Coussens LM (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7: 411-423.
31. Nikitin AY, Matoso A, Roy-Burman P (2007) Prostate stem cells and cancer. Histol Histopathol 22: 1043-1049.
32. Nikitin A, Nafus M, Zhou Z et al (2009) Prostate stem cells and cancer in animals. Stem cells and cancer. Humana, New York, pp 199-216.
33. Tsujimura A, Koikawa Y, Salm S et al (2002) Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol 157: 1257-1265.
34. Goto K, Salm SN, Coetzee S et al (2006) Proximal prostatic stem cells are programmed to regenerate a proximal-distal ductal axis. Stem Cells 24: 1859-1868.
35. Fuchs E, Tumbar T, Guasch G (2004) Socializing with the neighbors: stem cells and their niche. Cell 116: 769-778.
36. Salm SN, Burger PE, Coetzee S et al (2005) TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts. J Cell Biol 170: 81-90.
37. Lawson DA, Xin L, Lukacs R et al (2005) Prostate stem cells and prostate cancer. Cold Spring Harb Symp Quant Biol 70: 187-196.
38. Leong KG, Wang BE, Johnson L et al (2008) Generation of a prostate from a single adult stem cell. Nature 456: 804-808.
39. Goel HL, Li J, Kogan S et al (2008) Integrins in prostate cancer progression. Endocr Relat Cancer 15: 657-664.
40. Demetriou MC, Pennington ME, Nagle RB et al (2004) Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. Exp Cell Res 294: 550-558.
41. Ports MO, Nagle RB, Pond GD et al (2009) Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis. Cancer Res 69: 5007-5014.
42. Abate-Shen C, Shen MM (2002) Mouse models of prostate carcinogenesis. Trends Genet 18: S1-S5.
43. Huang J, Powell WC, Khodavirdi AC et al (2002) Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium. Cancer Res 62: 4812-4819.
44. Song Z, Wu X, Powell WC et al (2002) Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia. Cancer Res 62: 5096-5105.
45. Wang S, Gao J, Lei Q et al (2003) Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4: 209-221.
46. Ellwood-Yen K, Graeber TG, Wongvipat J et al (2003) Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4: 223-238.
47. Abdulkadir SA, Magee JA, Peters TJ et al (2002) Conditional loss of Nkx3. 1 in adult mice induces prostatic intraepithelial neoplasia. Mol Cell Biol 22: 1495-1503.
48. Roy-Burman P, Wu H, Powell WC et al (2004) Genetically defined mouse models that mimic natural aspects of human prostate cancer development. Endocr Relat Cancer 11: 225-254.
49. Chen Z, Trotman LC, Shaffer D et al (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725-730.
50. Zhou Z, Flesken-Nikitin A, Corney DC et al (2006) Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res 66: 7889-7898.
51. Zhong C, Saribekyan G, Liao CP et al (2006) Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis. Cancer Res 66: 2188-2194.
52. Abate-Shen C (2006) A new generation of mouse models of cancer for translational research. Clin Cancer Res 12: 5274-5276.
53. Bruxvoort KJ, Charbonneau HM, Giambernardi TA et al (2007) Inactivation of Apc in the mouse prostate causes prostate carcinoma. Cancer Res 67: 2490-2496.
54. Liao CP, Zhong C, Saribekyan G et al (2007) Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. Cancer Res 67: 7525-7533.
55. Zhou Z, Flesken-Nikitin A, Nikitin AY (2007) Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts. Cancer Res 67: 5683-5690.
56. Shen MM, Abate-Shen C (2007) Pten inactivation and the emergence of androgen-independent prostate cancer. Cancer Res 67: 6535-6538.
57. Carver BS, Pandolfi PP (2006) Mouse modeling in oncologic preclinical and translational research. Clin Cancer Res 12: 5305-5311.
58. Podsypanina K, Ellenson LH, Nemes A et al (1999) Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA 96: 1563-1568.
59. Roy-Burman P, Tindall DJ, Robins DM et al (2005) Androgens and prostate cancer: are the descriptors valid? Cancer Biol Ther 4: 4-5.
60. Abrahamsson PA (1999) Neuroendocrine differentiation in prostatic carcinoma. Prostate 39: 135-148.
61. Wang S, Garcia AJ, Wu M et al (2006) Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci USA 103: 1480-1485.
62. Liao CP, Liang M, Cohen MB et al (2010) Mouse prostate cancer cell lines established from primary and post-castration recurrent tumors. Horm Cancer 1: 44-54.
63. Yang S, Pham LK, Liao CP et al (2008) A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer. Cancer Res 68: 198-205.
64. Spangrude GJ, Heimfeld S, Weissman IL (1988) Purification and characterization of mouse hematopoietic stem cells. Science 241: 58-62.
65. Montanaro F, Liadaki K, Volinski J et al (2003) Skeletal muscle engraftment potential of adult mouse skin side population cells. Proc Natl Acad Sci USA 100: 9336-9341.
66. Falciatori I, Borsellino G, Haliassos N et al (2004) Identification and enrichment of spermatogonial stem cells displaying side-population phenotype in immature mouse testis. FASEB J 18: 376-378.
67. Matsuura K, Nagai T, Nishigaki N et al (2004) Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279: 11384-11391.
68. Burger PE, Xiong X, Coetzee S et al (2005) Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci USA 102: 7180-7185.
69. Xin L, Lawson DA, Witte ON (2005) The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 102: 6942-6947.
70. Lawson DA, Xin L, Lukacs RU et al (2007) Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci USA 104: 181-186.
71. Mulholland DJ, Xin L, Morim A et al (2009) Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res 69: 8555-8562.
72. Liao CP, Adisetiyo H, Liang M et al (2010) Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells. Cancer Res 70: 7294-7303.
73. Yang S, Lim M, Pham LK et al (2006) Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways. Cancer Res 66: 4285-4290.
74. Lim M, Zhong C, Yang S et al (2010) Runx2 regulates survivin expression in prostate cancer cells. Lab Invest 90: 222-233.
75. Wu X, Wu J, Huang J et al (2001) Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev 101: 61-69.
76. Lesche R, Groszer M, Gao J et al (2002) Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 32: 148-149.
77. Zhang J, Thomas TZ, Kasper S et al (2000) A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology 141: 4698-4710.
78. Lyons SK, Meuwissen R, Krimpenfort P et al (2003) The generation of a conditional reporter that enables bioluminescence imaging of Cre/loxP-dependent tumorigenesis in mice. Cancer Res 63: 7042-7046.